Stock Market ChatCOMMUNITY + RESEARCHMember login SMC NEWS & MARKET BRIEFINGS
Stock Market Chat reporting built from verified public sources, with direct citations, SMC context, and uncertainty kept visible.
MARKET NEWS
SMC’s post-close read showed call-heavy options activity in QQQ and SPY, while modeled GEX for both ETFs remained negative. That combination can make index moves more sensitive to momentum, but it is market context rather than a directional forecast.
Hercules Capital priced an underwritten public offering of $400.0 million aggregate principal amount of 6.70% notes due October 2029, expected to be delivered and paid for on October 8, 2026. The Notes are unsecured, pay interest semiannually, and the company said net proceeds will be used to repay indebtedness, fund investments, and for general corporate purposes.
TeraWulf announced an amended electric service agreement with Kentucky Power that increases contracted power capacity at its Muskie Data Campus in eastern Kentucky from 500 megawatts to 1 gigawatt and advances the planned delivery of the second 500 MW phase from 2030 to 2029, subject to regulatory and utility conditions.
HeartBeam announced that the U.S. Food and Drug Administration granted Breakthrough Device Designation for the HeartBeam System as a tool for assessing potential heart attacks at home. The designation recognizes the company’s 3D ECG technology, cites prior pilot data, and provides prioritized FDA interaction as HeartBeam plans a pivotal study and potential Medicare pathway.
Fathom Holdings Inc. (NASDAQ: FTHM) and Neighborhood Intelligence, Inc. (NASDAQ: NXH) announced on October 05, 2026 that their Boards have mutually agreed to terminate the previously announced merger agreement. Neighborhood Intelligence will retain ownership and control of its blockchain and digital asset investments while the companies say they will explore non-merger collaboration, including data sharing.
Benitec reported FDA feedback after a Type C meeting that led to a request for additional available data to support an open-label, single-arm pivotal study for BB-301. The company said the FDA will review the information on a timeline that would permit confirmation of the final pivotal study design in 1Q 2027 and that patient enrollment remains planned to begin in mid-2027.
Insmed announced that Sara Bonstein will step down as Chief Financial Officer and will continue as CFO through October 30, 2026, participating in the third-quarter 2026 earnings call; the company has begun a search for a successor and reaffirmed full-year 2026 revenue guidance for BRINSUPRI and ARIKAYCE.
Rezolute announced that after a preliminary review of Phase 3 sunRIZE data the U.S. Food and Drug Administration recommended a Type B pre-BLA meeting as a precursor to a potential BLA submission for congenital hyperinsulinism. The company reported that sunRIZE did not meet its prespecified primary and key secondary endpoints but submitted extensive CGM and other datasets for agency review and is evaluating overall BLA strategy alongside expected upLIFT topline results in tumor HI.
All In FutureTech Alliance Inc. (AIFA) held its inaugural annual conference in Las Vegas where leadership described a strategy focused on AI applications rather than foundational model or semiconductor development, highlighted two AI products in internal and early external use, and announced plans to position its Las Vegas venue as a year-round showcase and market-entry platform.
Redwire announced a follow-on contract from Axiom Space to develop and deliver two Roll-Out Solar Array (ROSA) wings for the second module of Axiom Station. The release reiterates Redwire’s ROSA heritage and provides program timing that places the first module launch in 2028 and the second module planned to launch less than a year after the first.
OS Therapies named Kerry Clem as Chief Commercial Officer and Frank Knuettel II as Chief Financial Officer to lead commercialization planning for Herlystic (OST-HER2; daznelimgene lisbac). The company described regulatory and financing actions intended to support potential launches in the U.K., U.S., and Europe.
ClearSign reports it received a purchase order for a ClearSign Core ™ M1 burner from Tulsa Heaters Midstream (THM). The unit is the fourth sold to THM for a West Texas customer and is expected to be delivered in the fourth quarter of 2026.
Airship AI said it was awarded $29.0 million in firm-fixed-price, brand-name-only contracts from an agency within the Department of Homeland Security with a six-month period of performance. The awards fund work across Acropolis software, Outpost AI and Fortress AI platforms, and turnkey hardware, and the company expects new agentic AI functionality in Ask Airship before the end of 2026.
Blade announced the seasonal return of BLADEone, a 16-seat enhanced jet service operated in partnership with Aero and USAC Airways 695, running between Westchester County Airport and Palm Beach or Miami-Opa Locka Executive Airport from November 19, 2026 through May 2, 2027. The service will use retrofitted commercial jets and operate from private terminals and lounges.
Achieve Life Sciences appointed Benjamin Halladay, CPA, as Chief Financial Officer effective October 5, 2026. The company describes his prior role as CFO at Esperion Therapeutics and positions the hire as part of preparation for potential commercialization of cytisinicline.
Applied Digital reports that it has achieved Ready for Service for the second phase of Building 2 at its Polaris Forge 1 campus, adding 75 MW of critical IT load and bringing the site to 250 MW operational capacity. The company says the campus is fully leased and contracted to deliver 400 MW at full buildout.
ChronoScale reported that two new customer agreements, including an expansion with an existing AI infrastructure customer and a deal with a new customer, together with existing contracts and the current deployment schedule, provide for $1 billion in annualized run-rate revenue by calendar Q3 2027. The company also completed the sale of its Ekso Bionics business unit and said the divestiture will allow it to focus on accelerated compute and AI infrastructure.
Roswell Park and Generate Biomedicines announced dosing of the first patient in a first-in-human phase 1 trial of GB-5267, an investigational autologous IL-18–armored CAR T-cell therapy targeting MUC16 for platinum-resistant ovarian cancer. The study will evaluate safety and tolerability and does not require lymphodepletion, according to the issuer release.
Spire Global announced the launch of the first three satellites built at its Boulder, Colorado manufacturing facility, flown on SpaceX’s Transporter-18 rideshare mission. The company says the U.S. site enables end-to-end onshore production and that, combined with U.K. and European capacity, it offers a total capacity of 300 to 400 satellites annually.
Resmed announced it will release financial and operational results for the first quarter of fiscal 2027 on Thursday, October 29, 2026, after the New York Stock Exchange closes, followed by a management webcast at 1:30 p.m. PT / 4:30 p.m. ET. A webcast replay and a phone replay window are provided with specified availability dates and access numbers.
KLA said it will review first quarter fiscal year 2027 results on Wednesday, October 28th at 2 p.m. PT and will publish results and supplemental disclosures after the market close; the live webcast and all disclosures will be posted on the company's Investor Relations page with a replay available after the event.
Evommune presented Phase 2a data for EVO301 in 70 adults with moderate-to-severe atopic dermatitis showing a primary endpoint result at Week 12, biomarker evidence of Th2 and broader pathway modulation, and a safety profile described as favorable; the company plans a subcutaneous Phase 2b dose-ranging trial in mid-2027.
Lōkahi Therapeutics™, a subsidiary of Glucotrack, Inc. (NASDAQ: GCTK), announced Qare™, a comparative health platform for GLP-1 medications, and said the platform is expected to become publicly available on October 14, 2026. The company positions Qare™ as a patient-centered tool to compare treatment experiences across cohorts and said additional therapeutic categories may follow.
All In FutureTech Alliance (Nasdaq: AIFA) will hold its AIFA 2026 Annual Gathering at the AIFA Arena in Las Vegas on October 3-4, 2026, with the Chairman delivering an annual strategy keynote and a 90-minute live Q&A. The main hall program will be livestreamed beginning at 6:00 p.m. Pacific Time on October 4 (9:00 a.m. Beijing Time on October 5).
Yext announced a multiplayer agent harness for its Scout product that creates a shared, context-rich workspace for marketing teams, partners, franchisees, and local managers. The company says the harness is live with Yext account teams and that customers can join a waitlist for early access.
Jade Biosciences reported preclinical data for JADE301 showing high-affinity, selective IFN-β neutralization, extended half-life after subcutaneous dosing in non-human primates, and a favorable GLP toxicology profile supporting a planned Phase 1 single ascending-dose study in 24 healthy volunteers expected to start in the fourth quarter of 2026 with interim data anticipated in the second half of 2027.
CollPlant announced completion of the LightSolver acquisition in September 2026 and highlighted a joint study reporting projected LPU time-to-solution acceleration up to 80,000×. For the quarter ended June 30, 2026, CollPlant reported GAAP revenues of $108,000, GAAP net loss of $2.7 million, and cash and cash equivalents of $2.6 million as of June 30, 2026.
Synchrony's CareCredit announced a strategic partnership with Vetspire to embed CareCredit financing into Vetspire's AI-enabled, cloud-based veterinary practice management system. The integration aims to present real-time financing at the point of care, streamline checkout workflows, and leverage Vetspire's AI features to reduce administrative friction for clinic teams.
Cyabra, Inc. (Nasdaq: CYAB) announced on September 30, 2026 that it was accepted as a member of the Special Operations Forces Rapid Acquisition Consortium for Emerging Requirements (SOF RACER), making the company eligible to respond to USSOCOM requirements and compete for potential awards through the SOF RACER process. The release highlights Cyabra’s narrative open-source intelligence offerings and recent U.S. public sector hiring and reseller arrangements as context for the membership.
Amaze Holdings announced a binding Letter of Intent to acquire the BullionFX assets, including the Alchemy platform, in a stock transaction valued at approximately $155 million. The release describes Alchemy as a gold-backed, Ethereum Layer 2 financial ecosystem and outlines planned product priorities and customary closing conditions.